Here's a look at some of the top legal news stories for medical device companies this week: Ex-sales rep sues Medtronic, claims she was fired for blowing the whistle; J&J's Ethicon settles Prolift pelvic mesh bellwether; Appeals court upholds AngioDynamics injunction, $160m penalty against Biolitec; Bard's Medafor wins injunction against CryoLife's PerClot Topical
A federal judge grants C.R. Bard's Medafor division's bid for an injunction barring U.S. sales of CryoLife's PerClot Topical hemostasis powder.
Hill-Rom looks to the energy industry for its new CEO, Steven Strobel, lured from retail energy services company BlueStar Energy.
Hill-Rom Holdings (NYSE:HRC) said it looked to the energy industry to replace James Saccaro as CFO, naming BlueStar Energy's former CFO Steven Strobel to the position.
, Dubilier & Rice
, Hansen Medical Inc.
, Hill-Rom Holdings Inc.
, Sotera Wireless
, Spine Wave
, GE Healthcare
An FDA advisory panel recommends that CryoLife's heart valve, the CryoValve allograft, be subject to its most-stringent pre-market approval protocol.
CryoLife names former Medtronic executive Pat Mackin as its new president & CEO.
CryoLife says it's in line for a $15 million payout due to its stake in Medafor, which C.R. Bard bought last week for some $280 million.
CryoLife Inc. (NYSE:CRY) said it's in line for a $15.1 million payout from the C.R. Bard (NYSE:BCR) acquisition of Minnesota-based Medafor for up to $280 million.
Hansen Medical inks an equity financing deal worth $93 million, sending share prices for the robotic surgery company up nearly 20% today.
Hansen Medical (NSDQ:HNSN) said it inked an equity financing deal for up to $93 million with a consortium of investors including Oracle Investment Management and private equity player Jack Schuler, a co-founder of Crabtree Partners.